Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN13331870
ISRCTN13331870
Active, not recruiting
Phase 1

An open controlled randomized clinical trial to study the clinical efficacy of the drug Eryxin produced by Namangan Pharm Plant

amangan Pharm Plant LTD0 sites60 target enrollmentFebruary 7, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSafety and efficacy in patients with rheumatoid arthritisMusculoskeletal Diseases

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Safety and efficacy in patients with rheumatoid arthritis
Sponsor
amangan Pharm Plant LTD
Enrollment
60
Status
Active, not recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 7, 2024
End Date
April 30, 2025
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
amangan Pharm Plant LTD

Eligibility Criteria

Inclusion Criteria

  • •1\. Adults aged 18 years old and over
  • •2\. Written informed consent to participate in the study
  • •3\. With rheumatoid arthritis

Exclusion Criteria

  • •1\. Pregnancy
  • •2\. Lactation
  • •3\. Children aged under 18 years old
  • •4\. Presence of hypersensitivity to the drug components
  • •5\. Patient's participation in other clinical trials within the last 30 days
  • •6\. Absence of informed written consent of the patient to participate in a clinical trial
  • •7\. Hypersensitivity to the drug
  • •8\. Genetically determined glucose\-6\-phosphate dehydrogenase deficiency (risk of hemolytic anemia)
  • •9\. History of gastrointestinal bleeding or perforation associated with NSAID therapy
  • •10\. Active peptic ulcer/bleeding or a history of recurrent peptic ulcer/bleeding (two or more cases of confirmed ulcer or bleeding)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Ayurvedic treatment for hypothyroidismHealth Condition 1: E039- Hypothyroidism, unspecified
CTRI/2019/08/020697Dr Vishala R Dodke
Completed
Not Applicable
Efficacy of a maintenance therapy with supplements containing indole-3-carbinol (I3C) and epigallocatechin-3-gallate (EGCG) in ovarian cancer patientsOvarian cancerCancer - Ovarian and primary peritoneal
ACTRN12616000394448Russian Scientific Center of Roentgenoradiology284
Not yet recruiting
Phase 2
To study the efficacy of garlic milk decoction in decreased breast milk secretion.
CTRI/2022/04/042216ALKA SARVAJEET SINGH
Not yet recruiting
Phase 2
To test efficacy of Indrayavadi yoga in heavy menstrual bleeding.Health Condition 1: N00-N99- Diseases of the genitourinary system
CTRI/2021/05/033326Priyanka Dilipkumar Sahu
Not yet recruiting
Phase 2
study the effect of neem leaf juice in worm infestation in childre
CTRI/2022/07/044339Yashwant ayurvedic College